Search by Drug Name or NDC

    NDC 00169-1837-02 Novolin 100 [iU]/mL Details

    Novolin 100 [iU]/mL

    Novolin is a SUBCUTANEOUS INJECTION, SUSPENSION in the HUMAN OTC DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is INSULIN HUMAN.

    Product Information

    NDC 00169-1837
    Product ID 0169-1837_c7164ea1-aa3e-4359-a3f0-a34c78e78398
    Associated GPIs 27104090001810
    GCN Sequence Number 016311
    GCN Sequence Number Description insulin NPH hum/reg insulin hm VIAL 70-30/ML SUBCUT
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 50001
    HICL Sequence Number 006215
    HICL Sequence Number Description INSULIN NPH HUMAN ISOPHANE/INSULIN REGULAR, HUMAN
    Brand/Generic Brand
    Proprietary Name Novolin
    Proprietary Name Suffix 70/30
    Non-Proprietary Name Human Insulin
    Product Type HUMAN OTC DRUG
    Dosage Form INJECTION, SUSPENSION
    Route SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN HUMAN
    Labeler Name Novo Nordisk
    Pharmaceutical Class Insulin [CS], Insulin [EPC]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA019991
    Listing Certified Through 2024-12-31

    Package

    NDC 00169-1837-02 (00169183702)

    NDC Package Code 0169-1837-02
    Billing NDC 00169183702
    Package 1 VIAL in 1 CARTON (0169-1837-02) / 10 mL in 1 VIAL
    Marketing Start Date 1991-06-25
    NDC Exclude Flag N
    Pricing Information N/A